Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Prestwickpharma Pages on BioPortfolio:

BioPortfolio - Biocorporate Search
... the development and marketing of small molecule drugs for chronic diseases of the central nervous system... www.prestwickpharma.com/ View full profile ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

Results from other life science and pharmaceutical sites:

Prestwick Pharmaceuticals, Inc.'s XENAZINE(R) Approved by FDA for ...
18 Aug 2008 ... For more information, go to http://www.prestwickpharma.com. CONTACT: Jessica Carlson, +1-312-284-4705, jcarlson@wcpglobal.com, for ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107130...

BMC Neurology
This study was funded by a grant from Prestwick Pharma- ceuticals, Inc. ( subsequently acquired by Biovail Pharma- ceuticals) to the University of
Rochester ...
http://www.biomedcentral.com/content/pdf/1471-2377-9-62.pdf...

Canada. Biovail to purchase Prestwick
Biovail Corp. moved forward with its plan to shift its focus to treatments for the central nervous.
http://www.canada.com/ottawacitizen/news/bustech/story.html?...

Prestwick Pharmaceuticals, Inc. Company Profile - Yahoo! Finance
Presto! Prestwick Pharmaceuticals hopes profits materialize from its work to develop drugs for chronic disorders of the central nervous system. ...
http://biz.yahoo.com/ic/127/127612.html...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.